Physician profile
Michael C Allen
NPI 1487681565
$23,712.54
in general payments reported to CMS, 2019-2025
50 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $227 · 2021: $418 · 2022: $230 · 2023: $856 · 2024: $21K · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $20K · Food and Beverage: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $19,968.00 |
| Food and Beverage | $2,074.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19,968.00 | 2024 | |
| Smith+Nephew, INC. | $708.77 | 2019-2025 | Collagenase Santyl, Regranex, Grafix |
| Stryker Corporation | $397.72 | 2019-2025 | Iconix, Alphavent, Flexband |
| Epsfl, LLC | $326.45 | 2023 | |
| Kerecis Limited | $250.23 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Royal Biologics, INC. | $166.22 | 2024-2025 | |
| Polymedics Innovations INC. | $164.64 | 2023 | |
| Paratek Pharmaceuticals, INC. | $152.11 | 2022-2025 | Nuzyra |
| Polynovo North America LLC | $145.72 | 2021-2025 | Novosorb Btm |
| Osiris Therapeutics INC. | $143.43 | 2019 | |
| Horizon Therapeutics Plc | $118.54 | 2019-2023 | Krystexxa |
| Amgen INC. | $111.23 | 2024-2025 | Krystexxa |
| Djo, LLC | $93.72 | 2020 | |
| Integra Lifesciences Corporation | $71.86 | 2022 | |
| Next Science LLC | $69.96 | 2025 | Xperience, Blastx |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.